vs

Side-by-side financial comparison of Cognizant (CTSH) and Sempra (SRE). Click either name above to swap in a different company.

Cognizant is the larger business by last-quarter revenue ($5.3B vs $3.3B, roughly 1.6× Sempra). Cognizant runs the higher net margin — 12.2% vs 10.7%, a 1.4% gap on every dollar of revenue. On growth, Sempra posted the faster year-over-year revenue change (6.9% vs -73.0%). Cognizant produced more free cash flow last quarter ($781.0M vs $-2.2B). Over the past eight quarters, Cognizant's revenue compounded faster (4.9% CAGR vs -5.8%).

Cognizant Technology Solutions Corporation is an American multinational information technology consulting and outsourcing company originally founded in India. It is headquartered in Teaneck, New Jersey, United States. Cognizant is part of the NASDAQ-100 and trades under CTSH. It was founded in Chennai, India, as an in-house technology unit of Dun & Bradstreet in 1994, and started serving external clients in 1996.

Sempra is a North American public utility holding company based in San Diego, California. The company is one of the largest utility holding companies in the United States with nearly 40 million consumers.

CTSH vs SRE — Head-to-Head

Bigger by revenue
CTSH
CTSH
1.6× larger
CTSH
$5.3B
$3.3B
SRE
Growing faster (revenue YoY)
SRE
SRE
+79.9% gap
SRE
6.9%
-73.0%
CTSH
Higher net margin
CTSH
CTSH
1.4% more per $
CTSH
12.2%
10.7%
SRE
More free cash flow
CTSH
CTSH
$3.0B more FCF
CTSH
$781.0M
$-2.2B
SRE
Faster 2-yr revenue CAGR
CTSH
CTSH
Annualised
CTSH
4.9%
-5.8%
SRE

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CTSH
CTSH
SRE
SRE
Revenue
$5.3B
$3.3B
Net Profit
$648.0M
$352.0M
Gross Margin
Operating Margin
16.0%
7.2%
Net Margin
12.2%
10.7%
Revenue YoY
-73.0%
6.9%
Net Profit YoY
18.7%
-47.9%
EPS (diluted)
$1.34
$0.53

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTSH
CTSH
SRE
SRE
Q1 26
$5.3B
Q4 25
$5.3B
$3.3B
Q3 25
$5.4B
$2.8B
Q2 25
$5.2B
$2.7B
Q1 25
$5.1B
$3.7B
Q4 24
$5.1B
$3.1B
Q3 24
$5.0B
$2.6B
Q2 24
$4.8B
$2.5B
Net Profit
CTSH
CTSH
SRE
SRE
Q1 26
$648.0M
Q4 25
$648.0M
$352.0M
Q3 25
$274.0M
$95.0M
Q2 25
$645.0M
$473.0M
Q1 25
$663.0M
$917.0M
Q4 24
$546.0M
$676.0M
Q3 24
$582.0M
$649.0M
Q2 24
$566.0M
$725.0M
Operating Margin
CTSH
CTSH
SRE
SRE
Q1 26
16.0%
Q4 25
16.0%
7.2%
Q3 25
16.0%
10.6%
Q2 25
15.6%
17.3%
Q1 25
16.7%
21.5%
Q4 24
14.8%
35.0%
Q3 24
14.6%
12.9%
Q2 24
14.6%
18.8%
Net Margin
CTSH
CTSH
SRE
SRE
Q1 26
12.2%
Q4 25
12.2%
10.7%
Q3 25
5.1%
3.4%
Q2 25
12.3%
17.5%
Q1 25
13.0%
24.9%
Q4 24
10.7%
22.0%
Q3 24
11.5%
25.3%
Q2 24
11.7%
29.2%
EPS (diluted)
CTSH
CTSH
SRE
SRE
Q1 26
$1.34
Q4 25
$1.35
$0.53
Q3 25
$0.56
$0.12
Q2 25
$1.31
$0.71
Q1 25
$1.34
$1.39
Q4 24
$1.10
$1.04
Q3 24
$1.17
$1.00
Q2 24
$1.14
$1.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTSH
CTSH
SRE
SRE
Cash + ST InvestmentsLiquidity on hand
$1.9B
$29.0M
Total DebtLower is stronger
$576.0M
$29.0B
Stockholders' EquityBook value
$15.0B
$31.6B
Total Assets
$20.7B
$110.9B
Debt / EquityLower = less leverage
0.04×
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTSH
CTSH
SRE
SRE
Q1 26
$1.9B
Q4 25
$1.9B
$29.0M
Q3 25
$2.4B
$5.0M
Q2 25
$1.8B
$155.0M
Q1 25
$2.0B
$1.7B
Q4 24
$2.2B
$1.6B
Q3 24
$2.0B
$560.0M
Q2 24
$2.2B
$228.0M
Total Debt
CTSH
CTSH
SRE
SRE
Q1 26
$576.0M
Q4 25
$29.0B
Q3 25
$29.0B
Q2 25
$34.9B
Q1 25
$33.3B
Q4 24
$31.6B
Q3 24
$31.0B
Q2 24
$29.0B
Stockholders' Equity
CTSH
CTSH
SRE
SRE
Q1 26
$15.0B
Q4 25
$15.0B
$31.6B
Q3 25
$14.9B
$31.2B
Q2 25
$15.3B
$31.7B
Q1 25
$14.9B
$31.6B
Q4 24
$14.4B
$31.2B
Q3 24
$14.5B
$29.7B
Q2 24
$13.9B
$29.5B
Total Assets
CTSH
CTSH
SRE
SRE
Q1 26
$20.7B
Q4 25
$20.7B
$110.9B
Q3 25
$20.1B
$106.9B
Q2 25
$20.2B
$99.9B
Q1 25
$20.0B
$99.0B
Q4 24
$20.0B
$96.2B
Q3 24
$20.2B
$93.7B
Q2 24
$18.6B
$90.5B
Debt / Equity
CTSH
CTSH
SRE
SRE
Q1 26
0.04×
Q4 25
0.92×
Q3 25
0.93×
Q2 25
1.10×
Q1 25
1.05×
Q4 24
1.01×
Q3 24
1.04×
Q2 24
0.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTSH
CTSH
SRE
SRE
Operating Cash FlowLast quarter
$858.0M
$1.2B
Free Cash FlowOCF − Capex
$781.0M
$-2.2B
FCF MarginFCF / Revenue
14.6%
-67.7%
Capex IntensityCapex / Revenue
104.0%
Cash ConversionOCF / Net Profit
1.32×
3.38×
TTM Free Cash FlowTrailing 4 quarters
$3.1B
$-6.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTSH
CTSH
SRE
SRE
Q1 26
$858.0M
Q4 25
$858.0M
$1.2B
Q3 25
$1.2B
$1.1B
Q2 25
$398.0M
$784.0M
Q1 25
$400.0M
$1.5B
Q4 24
$920.0M
$1.4B
Q3 24
$847.0M
$1.0B
Q2 24
$262.0M
$669.0M
Free Cash Flow
CTSH
CTSH
SRE
SRE
Q1 26
$781.0M
Q4 25
$781.0M
$-2.2B
Q3 25
$1.2B
$-1.5B
Q2 25
$331.0M
$-1.5B
Q1 25
$323.0M
$-854.0M
Q4 24
$837.0M
$-1.1B
Q3 24
$791.0M
$-913.0M
Q2 24
$183.0M
$-1.2B
FCF Margin
CTSH
CTSH
SRE
SRE
Q1 26
14.6%
Q4 25
14.6%
-67.7%
Q3 25
21.4%
-52.6%
Q2 25
6.3%
-56.3%
Q1 25
6.3%
-23.2%
Q4 24
16.5%
-35.4%
Q3 24
15.7%
-35.5%
Q2 24
3.8%
-49.4%
Capex Intensity
CTSH
CTSH
SRE
SRE
Q1 26
Q4 25
1.4%
104.0%
Q3 25
1.2%
92.9%
Q2 25
1.3%
85.3%
Q1 25
1.5%
63.5%
Q4 24
1.6%
79.9%
Q3 24
1.1%
75.3%
Q2 24
1.6%
76.4%
Cash Conversion
CTSH
CTSH
SRE
SRE
Q1 26
1.32×
Q4 25
1.32×
3.38×
Q3 25
4.48×
11.68×
Q2 25
0.62×
1.66×
Q1 25
0.60×
1.62×
Q4 24
1.68×
2.02×
Q3 24
1.46×
1.57×
Q2 24
0.46×
0.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTSH
CTSH

Health Sciences$1.6B30%
Financial Services$1.6B30%
Products and Resources$1.3B25%
Communications, Media and Technology$808.0M15%

SRE
SRE

Segment breakdown not available.

Related Comparisons